LOXLEBI Trademark

Trademark Overview

On Monday, January 18, 2016, a trademark application was filed for LOXLEBI with the United States Patent and Trademark Office. The USPTO has given the LOXLEBI trademark a serial number of 86878788. The federal status of this trademark filing is REGISTERED as of Tuesday, September 24, 2019. This trademark is owned by Gilead Sciences Ireland UC. The LOXLEBI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis
loxlebi

General Information

Serial Number86878788
Word MarkLOXLEBI
Filing DateMonday, January 18, 2016
Status700 - REGISTERED
Status DateTuesday, September 24, 2019
Registration Number5865027
Registration DateTuesday, September 24, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, immunological, oncological and hematological conditions, diseases and disorders; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia, and lymphoma; pharmaceutical preparations for the treatment of hepatitis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 22, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Wednesday, April 6, 2016SUSPENSION LETTER WRITTEN
Thursday, January 21, 2016NEW APPLICATION ENTERED
Friday, January 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 6, 2016ASSIGNED TO EXAMINER
Wednesday, April 6, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, April 6, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 28, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, May 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, May 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, May 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 30, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, November 30, 2016SOU EXTENSION 1 FILED
Wednesday, November 30, 2016SOU EXTENSION 1 GRANTED
Friday, December 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 24, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, May 24, 2017SOU EXTENSION 2 FILED
Wednesday, May 24, 2017SOU EXTENSION 2 GRANTED
Friday, May 26, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 30, 2017SOU TEAS EXTENSION RECEIVED
Thursday, November 30, 2017SOU EXTENSION 3 FILED
Thursday, November 30, 2017SOU EXTENSION 3 GRANTED
Saturday, December 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 13, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, June 13, 2018SOU EXTENSION 4 FILED
Wednesday, June 13, 2018SOU EXTENSION 4 GRANTED
Friday, June 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 12, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, December 12, 2018SOU EXTENSION 5 FILED
Thursday, December 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 20, 2018SOU EXTENSION 5 GRANTED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 24, 2019TEAS DELETE 1(B) BASIS RECEIVED
Friday, May 24, 2019NOTICE OF ALLOWANCE CANCELLED
Saturday, August 17, 20191(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, September 24, 2019REGISTERED-PRINCIPAL REGISTER
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 24, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

loxlebi preparations pharmaceutical treatment diseases anti infectious fibrotic prevention myeloma hepatitis